These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 18173541

  • 1. Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.
    Aroni K, Mastoraki A, Agrogiannis G, Ioannidis E, Patsouris E.
    Int J Dermatol; 2007 Dec; 46(12):1321-2. PubMed ID: 18173541
    [No Abstract] [Full Text] [Related]

  • 2. Keratoacanthoma centrifugum marginatum: a diagnostic and therapeutic challenge.
    Divers AK, Correale D, Lee JB.
    Cutis; 2004 Apr; 73(4):257-62. PubMed ID: 15134326
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A case of multiple keratoacanthoma centrifugum marginatum.
    Mangas C, Bielsa I, Ribera M, Fernández-Figueras MT, Ferrándiz C.
    Dermatol Surg; 2004 May; 30(5):803-6. PubMed ID: 15099330
    [Abstract] [Full Text] [Related]

  • 5. Topical treatment with imiquimod may induce regression of facial keratoacanthoma.
    Dendorfer M, Oppel T, Wollenberg A, Prinz JC.
    Eur J Dermatol; 2003 May; 13(1):80-2. PubMed ID: 12609789
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream.
    Peris K, Micantonio T, Fargnoli MC.
    Eur J Dermatol; 2003 May; 13(4):413-4; author reply 415. PubMed ID: 12948930
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Multiple keratoacanthoma centrifugum marginatum].
    Cherif F, Mebazaa A, Kort R, Makni N, Haouet S, Mokni M, Ben Osman Dhahri A.
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 1):413-5. PubMed ID: 12055541
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream.
    Di Lernia V, Ricci C, Albertini G.
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):626-9. PubMed ID: 15324413
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Imiquimod as a possible treatment for keratoacanthoma.
    Bhatia N.
    J Drugs Dermatol; 2004 Sep; 3(1):71-4. PubMed ID: 14964750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Keratoacanthoma centrifugum marginatum: treatment with intralesional bleomycin.
    de la Torre C, Losada A, Cruces MJ.
    J Am Acad Dermatol; 1997 Dec; 37(6):1010-1. PubMed ID: 9418780
    [No Abstract] [Full Text] [Related]

  • 18. Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma.
    Paternò EJ, Campione E, Diluvio L, Orlandi A, Chimenti S.
    Dermatol Online J; 2008 Mar 15; 14(3):8. PubMed ID: 18627710
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.